Form D · Biotechnology
SYNCRO MEDICAL INNOVATIONS INC
Youngstown, OH · CIK 0001349515
Offering snapshot reported Jan 20, 2012 · SEC filing
- Reported sold
- $250K Offering amount: $250K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 9, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 20, 2012 | Initial | $250,000 | No comparison | 1 | SEC filing |
| May 10, 2011 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jul 30, 2010 | Initial | $500,000 | No comparison | 2 | SEC filing |
| May 3, 2010 | Amendment | $800,000 | $300,000vs Dec 28, 2009 | 1 | SEC filing |
| Dec 28, 2009 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Aug 21, 2009 | Initial | $500,000 | No comparison | 2 | SEC filing |
| Mar 16, 2009 | Paper | Not reported | No comparison | Not reported | |
| Sep 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 17, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 4, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 17, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 13, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 27, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-172208
Source: Form D, filed Jan 20, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Phil Fleck | Director |
| Paul Frankhouser | Director |
| Sabry A. Gabriel | Director |
| Aaron Sandoski | Director |
| Gary Wakeford | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
20 Federal Street Suite M5 B
Youngstown, OH, 44503
Youngstown, OH, 44503